1. Home
  2. VTSI vs SER Comparison

VTSI vs SER Comparison

Compare VTSI & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

HOLD

Current Price

$3.09

Market Cap

51.0M

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$2.41

Market Cap

42.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTSI
SER
Founded
1993
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.0M
42.0M
IPO Year
1999
2024

Fundamental Metrics

Financial Performance
Metric
VTSI
SER
Price
$3.09
$2.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$15.00
AVG Volume (30 Days)
34.0K
57.1K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$185,971.00
$130,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$27.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
132.14
52 Week Low
$2.88
$1.22
52 Week High
$6.29
$5.83

Technical Indicators

Market Signals
Indicator
VTSI
SER
Relative Strength Index (RSI) 50.00 48.65
Support Level $2.98 $1.69
Resistance Level $3.25 $2.95
Average True Range (ATR) 0.17 0.19
MACD -0.00 -0.05
Stochastic Oscillator 26.02 13.99

Price Performance

Historical Comparison
VTSI
SER

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of judgmental use-of-force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company operates in six segments, which include Simulators and Accessories, Extended Service, Customized software and Custom content, Installation and Training, Design and Prototyping, and Subscription Training Equipment Partnership. The majority of its revenue is generated from the Simulators and Accessories segment.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

Share on Social Networks: